# Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients

> **NCT03295058** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Severe Aplastic Anemia

## Interventions

- **DRUG:** Non ATG Conditioning regimen
- **DRUG:** GVHD Prophylaxis
- **PROCEDURE:** Allogenic Stem Cell Transplantation
- **DRUG:** ATG conditioning regimen

## Key facts

- **NCT ID:** NCT03295058
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03295058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03295058, "Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03295058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*